The Rituximab Drug Market in North America is witnessing steady growth, supported by the rising burden of cancer and autoimmune disorders, increasing use of monoclonal antibody therapies, and well-established healthcare and pharmaceutical infrastructure. The region benefits from strong research and development capabilities, advanced oncology centers, favorable access to innovative...